The Kentucky Network for Innovation and Commercialization (KYNETIC) has funded nine proof-of-concept project grants in the latest round, Cycle 5, of early-stage commercialization grants.  

The Kynetic Program – led by the University of Kentucky (UK), University of Louisville (UofL), Kentucky Cabinet for Economic Development, and Kentucky Commercialization Ventures – awards grants to faculty, staff and student teams all across the state for new, innovative products with the potential to have an impact on human health.  Therapeutic, preventative, device, testing, software – i.e., any type of product – for any disease or health care-related area are eligible for funding.

In this latest round, Dr. Levi Beverly, Associate Professor of Medicine and Member of the Brown Cancer Center, received a grant entitled “Novel Copper Complexes As Cancer-Selective Therapeutics”.